Replies to post #402017 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Approval cannot occur without Sawston being certified. Mature Pivotal phase III trials trigger companies to provide much more proof of readiness than you might imagine.

Sawston will still be able to make DCVax-l for compassionate use if Sawston is certified, regardless if we have TLD then or not.

[exwannabe]

Sawston is useless without tld.

Cognate ended up being worth about $800M.

Avid (CDMO, previously PPHM) has a market cap over $1B despite being no more than a CDMO since PPHM's only product flamed out in trials.

Sawston has a value.

The only question is who pockets the cash, and why NWBO does not disclose the highly material related party agreements as required by law.